Assignee
CELLARTGEN INC
KR·4 granted patents·16 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
20 records- 0162US2024026268A1Microfluidic hanging drop culture device for culturing cell aggregateCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 0259US2023201109A1Bio-inspired tissue-adhesive hydrogel patch for preventing or treating cartilage or bone diseaseCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 0356US2024142438A1Multi-organ modelCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 0456US2024228973A9Non-alcoholic fatty liver artificial tissue modelCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 0555US2023355518A1Decellularized tissue-derived extracellular matrix functionalized with phenol derivative and use thereofCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 0655US2023374465A1Esophagus extracellular matrix-derived scaffold for culture and transplantation of esophageal organoid, and method of preparing the sameCELLARTGEN INC·Filed 2021·Application pending·0 cites
- 0754US2023310715A1Extracellular matrix-loaded bio-inspired tissue-adhesive hydrogel patchCELLARTGEN INC·Filed 2021·Application pending·0 cites
- 0853US12569451B2Bio-inspired tissue-adhesive hydrogel patch and uses thereofCELLARTGEN INC·Filed 2019·Granted Mar 10, 2026·0 cites·11 claims
- 0953US2023293768A1Tissue gell for transplantation using decellularized extracellular matrix and method of preparing the sameCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 1052US12540297B2Microfluidic device for cerebrovascular simulation and high-efficiency blood-brain barrier simulation system comprising sameCELLARTGEN INC·Filed 2019·Granted Feb 3, 2026·0 cites·14 claims
- 1152US11725173B2Highly efficient organoid culture device and systemCELLARTGEN INC·Filed 2019·Granted Aug 15, 2023·0 cites·11 claims
- 1252US2023340422A1Adipose extracellular matrix-derived scaffold for culturing organoid and preparing method thereofCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 1351US2024016971A1Phenol derivative-modified, tissue-derived extracellular matrix derivative for construction of artificial tissueCELLARTGEN INC·Filed 2023·Application pending·0 cites
- 1448US2024191222A1Tissue-derived extracellular matrix derivative modified with acryl group and use thereofCELLARTGEN INC·Filed 2022·Application pending·0 cites
- 1546US12534704B2Organ extracellular matrix-derived scaffold for culture and transplantation of organoid and method of preparing the sameCELLARTGEN INC·Filed 2021·Granted Jan 27, 2026·0 cites·1 claims
- 1645US2024026300A1Kidney extracellular matrix-derived scaffold for culture and transplantation of kidney organoid and method of preparing the sameCELLARTGEN INC·Filed 2021·Application pending·0 cites
- 1745US2023399624A1Pancreas extracellular matrix derived scaffold for culture and transplantation of pancreatic organoid and method of preparing the sameCELLARTGEN INC·Filed 2021·Application pending·0 cites
- 1844US2022143190A1Hydrogel comprising hyaluronic acid modified by serotonin and uses thereofCELLARTGEN INC·Filed 2020·Application pending·0 cites
- 1944US2023285315A1Exosome-loaded bio-inspired tissue-adhesive hydrogel patchCELLARTGEN INC·Filed 2021·Application pending·0 cites
- 2041US2023108699A1Heart extracellular matrix-derived scaffold for culture and transplantation of cardiac organoid and method of preparing the sameCELLARTGEN INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →